webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide

  CAS No.: 1226221-04-0   Cat No.: BADC-00556 4.5  

N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide is an aldehyde-bearing ADC linker designed for selective conjugation and enhanced antibody-drug conjugate stability, optimizing targeted drug delivery in cancer treatment.

N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide

Structure of 1226221-04-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C18H19NO4
Molecular Weight
313.35
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
N-[2-(2-ethoxyphenoxy)ethyl]-4-formylbenzamide
Canonical SMILES
CCOC1=CC=CC=C1OCCNC(=O)C2=CC=C(C=C2)C=O
InChI
InChI=1S/C18H19NO4/c1-2-22-16-5-3-4-6-17(16)23-12-11-19-18(21)15-9-7-14(13-20)8-10-15/h3-10,13H,2,11-12H2,1H3,(H,19,21)
InChIKey
ZWBZNLROLFKZLF-UHFFFAOYSA-N
Shipping
Room temperature, or blue ice upon request.

Applications in Medicinal Chemistry: N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide is an important compound in medicinal chemistry due to its potential for developing novel therapeutic agents. The compound features a distinctive ethoxyphenoxy group and a formylbenzamide moiety, making it a versatile scaffold for designing bioactive molecules. Researchers are exploring its use in creating selective inhibitors for various enzymes involved in critical biological processes. Its structure enables it to interact with specific molecular targets, such as kinases, receptors, or enzymes, which are often implicated in diseases like cancer, inflammation, and neurodegenerative disorders. By modifying these pathways, this compound could offer new strategies for drug development with improved specificity and efficacy.

Drug Delivery and Targeted Therapies: Another significant application of N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide is in the field of drug delivery. The ethoxyphenoxy group enhances its solubility in both aqueous and organic environments, making it suitable for incorporation into drug delivery systems like nanoparticles or liposomes. These systems can facilitate the controlled release of therapeutic agents, ensuring that drugs are delivered directly to target tissues with minimal side effects. This compound’s ability to enhance the stability and bioavailability of drugs makes it particularly useful in cancer therapy, where precise drug targeting and reduced systemic toxicity are crucial. Its integration into nanocarriers could significantly improve the efficacy of existing drugs.

Enzyme Inhibition and Molecular Targeting: N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide also holds promise in the inhibition of specific enzymes and proteins involved in disease pathways. The formylbenzamide group can interact with a variety of biological targets, including proteases and kinases, making it an excellent candidate for enzyme inhibition studies. In particular, the compound has shown potential in targeting enzymes that play a central role in cellular signaling, apoptosis, and immune response regulation. This ability to selectively modulate enzyme activity is important for developing drugs that can intervene in complex disease processes, offering a targeted approach with fewer off-target effects.

Anti-inflammatory and Immunomodulatory Applications: Due to its bioactive structure, N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide is being studied for its anti-inflammatory and immunomodulatory properties. Chronic inflammation is a key feature in several diseases, including rheumatoid arthritis, inflammatory bowel disease, and autoimmune conditions. The compound’s ability to interact with inflammatory signaling pathways could make it useful in reducing inflammation and modulating immune responses. By targeting specific inflammatory mediators or pathways, N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide could lead to the development of more effective treatments for these conditions with reduced systemic toxicity.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: NH2-PEG4-Val-Cit-PAB-OH | N-(2-(2-Ethoxyphenoxy)ethyl)-4-Formylbenzamide
Send Inquiry
Verification code
Inquiry Basket